80wk Downtrend — falling+below (sma 20.33 vs px 12.55)
200wk Downtrend — falling+below (sma 2459 vs px 12.55)
Short Attack — velZ +2.13 · age 49w×0.76 · 23.88%
Seasonal Headwind — september med -18.5% (mag 2/3) · posClose 14.29% (rel 2/3) · n14 ×1 = 11
About Tonix Pharmaceuticals Holding Corp
Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: May 10, 2012
Headquarters: 200 Connell Drive, Berkeley Heights, NJ, United States, 07928
Founder-Led: Yes — Seth Lederman (Co-Founder, President, CEO & Chairman)
Key Metrics
Current Price
$12.55
Market Cap
$213M
Float
14.1M
Shares Outstanding
17.2M
Price/Sales (TTM)
7.30
vs. Analyst Target
+237.8% to analyst PT
Operating Margin (TTM)
-314.05%
Revenue (TTM)
$29.1M
Dividend Rate
None
Analyst Target Price
$42.40 (2 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$2.9M
-$50.4M
-$50.5M
-$50.5M
2021
N/A
-$92.2M
-$92.3M
-$92.3M
2022
$9.0M
-$115M
-$112M
-$111M
2023
$7.8M
-$117M
$3.0M
-$112M
2024
$10.1M
-$130M
$2.3M
-$74.3M
2025
$13.1M
-$124M
$4.5M
-$122M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Sep 2025
$3.3M
-$32.0M
Dec 2025
$5.4M
-$46.9M
Mar 2026
$6.9M
-$40.2M
Jun 2026
$13.5M
-$40.6M
Ownership & Float
Insider Ownership
0.1%
Institutional Ownership
56.1%
Short Float
25.5%
% of All Funds Holding
1.16%
Number of Funds Holding
102
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$11.97
Near-term / short-term trend
Weekly
40-Week SMA
$14.17
Medium-term trend
Weekly
80-Week SMA
$20.33
Cyclical trend (business cycle)
Weekly
200-Week SMA
$2458.97
Secular trend (multi-year)
Monthly
10-Month SMA
$13.71
Near-term monthly trend
Monthly
20-Month SMA
$20.49
Medium-term monthly trend
Monthly
40-Month SMA
$711.87
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$7.80
support
2.90x
16 months ago
$52.00
resistance
8.67x
23 months ago
$71.00
resistance
6.21x
24 months ago
$544.00
resistance
7.96x
25 months ago
Historical Earnings Reactions (57 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-0.17%
0.00%
31.58%
21.43%
-10.34%
1 Day
-1.71%
-0.44%
33.33%
11.43%
-31.37%
1 Week
-3.26%
-1.00%
43.86%
31.80%
-46.88%
2 Weeks
-5.21%
-4.22%
39.29%
30.38%
-53.70%
1 Month
-7.74%
-9.60%
26.79%
135.80%
-78.86%
Next earnings: October 29, 2026 (65 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
17.0%
64.3%
14
Feb
-17.7%
14.3%
14
Mar
4.4%
42.9%
14
Apr
-6.7%
21.4%
14
May
0.7%
35.7%
14
Jun
-5.3%
40.0%
15
Jul
-11.8%
26.7%
15
Aug
-16.2%
14.3%
14
Sep
-24.4%
14.3%
14
Oct
-6.4%
35.7%
14
Nov
-6.6%
35.7%
14
Dec
4.3%
42.9%
14
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.07%
39.5%
674
Tuesday
-0.48%
37.0%
737
Wednesday
-0.48%
36.8%
734
Thursday
-0.07%
37.2%
721
Friday
-0.11%
38.3%
720
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 56.1%
Insider Transactions — Smart Summary
Total insider ownership: 0.1%
Founder-led management: Seth Lederman (Co-Founder, President, CEO & Chairman)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Tonix Pharmaceuticals Holding Corp
(TNXP) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.